Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Clear vision is an undeniable need for everyone. The cataract and refractive surgeons fully understand that a local search for an ophthalmologist in Kansas City may begin with a simple question: can LASIK provide clear vision without glasses or contact lenses?  For many carefully selected patients, it can. Research reports strong visual outcomes and high […]

The post Considering LASIK? What the Evidence Says About Safety, Results and Side Effects appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Health systems frequently measure resilience in terms of hospital capacity, clinical skill, emergency preparedness, and medical technology. Less stressful operational processes also help a healthcare organization withstand stress. Documentation, communication processes, scheduling, staffing models, and administrative assistance can make the difference between a smooth week of care and a spike in unplanned demand. This is […]

The post Why Healthcare’s Resilience Depends on Unsung Operational Innovations appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Almost 7 million American adults suffer from it alone, and as many as 2% of adults suffer from it annually. However, no one has a particularly good grasp of, and it is so ubiquitous. When individuals begin to listen the word “herniated disc” they are going to assume surgery will be necessary. In fact, many […]

The post Herniated Disc: Symptoms, Causes, and Evidence-Backed Treatment Options appeared first on Medical News Bulletin.

The FDA approved belzutifan in combination with lenvatinib for adults with advanced renal cell carcinoma with a clear cell component following treatment with a PD-1 or PD-L1 inhibitor.
The combination of belzutifan (Welireg, Merck) plus lenvatinib (Lenvima, Eisai) is indicated for adults with locally advanced or metastatic ccRCC that progressed during or after PD-1/PD-L1 inhibitor therapy, or within 6 months of completing adjuvant PD-1 therapy.
The FDA based its decision on findings from the randomized, phase 3 LITESPARK-011 trial, which demonstrated a 26% improvement in PFS with belzutifan

Patients accustomed to wearing hydrogel contact lenses reported better comfort and reduced dryness with silicone hydrogel lenses, according to data from CooperVision.
“Although silicone hydrogel lenses now dominate new soft lens fits, approximately one-quarter of patients fit with daily disposable lenses globally are still wearing hydrogel materials,” study coauthor Jennifer Palombi, OD, FAAO, director of professional affairs, Americas, at CooperVision, told Healio. “Modern [silicone hydrogel] materials offer excellent oxygen transmission while also delivering comfort and

Senators asked Heidi Overton, MD, about some critical issues in medicine during her hearing to become FDA commissioner.
If confirmed, Overton would replace Martin Makary, MD, MPH, who resigned as FDA commissioner in May. Overton is currently deputy assistant to the president for domestic policy. She previously served as a White House fellow in Trump’s first term and chief policy officer and vice chair of the Center for a Healthy America at the America First Policy Institute, a conservative thinktank.
At the beginning of the hearing, Committee Chairman Sen. Bill Cassidy, MD, R-La., — typically

An FDA advisory panel expressed support for a blood test designed to detect early signs of multiple cancers, including some for which no screening alternative exists.
Members of the Medical Devices Advisory Committee’s Molecular and Clinical Genetics Panel voted 7 to 2 with one abstention that the benefits of Galleri (Grail Inc.) outweigh the potential risks for adults age 50 years or older, the population for which the test’s developer is seeking approval in the United States.
In separate votes, the panel unanimously agreed Galleri is safe for use in this population but was split on whether

Despite supporting vaccines, many U.S. adults forgo shots for influenza and other respiratory diseases because they are unclear about the recommendations, according to survey results released Thursday.
“Last year’s respiratory season was another reminder that these illnesses — flu, COVID-19, RSV and pneumococcal disease — while often common, are not always mild,” Robert H. Hopkins, Jr., MD, medical director of the National Foundation for Infectious Diseases (NFID), said during the organization’s annual respiratory season press conference.
“Last year we

Twenty-one states had adult obesity rates at or above 35% in 2025, according to a new report from Trust for America’s Health, or TFAH.
The new estimate represents an increase from 19 states in 2024 and no states in 2012, but a decrease from 23 states in 2023, TFAH said.
J. Nadine Gracia, MD, MSCE, TFAH president and CEO, said during a press briefing that the 2026 edition of TFAH’s annual obesity assessment “includes some encouraging news about adult obesity rates, but also raises red flags — that chronic disease prevention is at risk due to federal budget cuts, staff reductions and threats to

A 39-year-old Haitian woman at 26 weeks’ gestation with a medical history of pregestational diabetes, obesity and preeclampsia presented to the emergency department because of sudden vision loss in the left eye.
She reported approximately 6 months of nearly daily predominantly left-sided throbbing headaches that began during pregnancy and were atypical for her baseline headaches, which typically improved with acetaminophen. In the 5 days preceding presentation, she also noted intermittent blurry vision in the left eye, often occurring concurrently with the headaches. On the day of